Semaglutide Oral Spray is a synthetic peptide formulation designed to interact with metabolic regulatory pathways, including those associated with glucose homeostasis, appetite signaling, and endocrine system function, which play key roles in energy balance, insulin sensitivity, and physiological regulation.

It is engineered as a stabilized peptide system based on semaglutide, a long-acting analog of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose metabolism. Supplied as a clear aqueous oral spray solution, Semaglutide Oral Spray is utilized in research models to investigate alternative delivery mechanisms and peptide absorption across oral mucosal surfaces, as well as its interaction with metabolic and hormonal signaling pathways.

This compound features specific structural and biochemical properties that:

Support modulation of incretin receptor activity, particularly GLP-1 receptor signaling pathways involved in glucose regulation
Influence insulin secretion dynamics and glucagon suppression in experimental environments
Provide enhanced resistance to enzymatic degradation compared to endogenous peptide hormones
Promote sustained interaction with receptor systems involved in appetite regulation and metabolic control

These characteristics allow Semaglutide Oral Spray to be utilized in research systems investigating peptide-based metabolic regulation, receptor binding dynamics, endocrine signaling pathways, and downstream effects on energy balance and glucose utilization.

Semaglutide Oral Spray is supplied as a clear, pre-formulated aqueous solution and is intended for laboratory research purposes only, not for human or veterinary therapeutic use.

Purity: High-purity, >95%
Form: Clear aqueous oral spray solution
Storage: Store at 2–8°C, protected from light
Solubility: Fully soluble in aqueous solutions (pre-formulated)
Usage: For use in laboratory research, assays, and studies in endocrinology, metabolism, and cellular biology